Skip to main content
. 2015 Oct 21;4(4):263–273. doi: 10.1159/000367751

Table 2.

Dosage levels of sorafenib and low-dose FP administered to patients with advanced HCC and DLT

Cohort Sorafenib (mg/day) CDDP (mg/m2, day 1, 8) 5-FU (mg/m2/day, Days 1–5, Days 8–12) DLT Remarks
0 800 10 170
1 800 14 170 DLT 2/6 EM in 1 case PLT and EM in 1 case Starting dose
2 800 14 330 DLT 1/6 (EM) EM in 1 case
3 800 20 330 DLT 0/6 Recommended dose

EM=Erythema multiforme; PLT=thrombocytopenia; FP=CDDP+5-FU.